BioCentury
ARTICLE | Finance

We all fall down

Biotech stocks down across the board in 4Q18 from 3Q18 highs

January 12, 2019 12:23 AM UTC

After an exuberant third quarter that put biotech indexes near their 2015 highs, all market cap tiers fell in 4Q18, eliminating the first nine month’s gains and losing $291.2 billion in aggregate value.

Median losses were 20-22% for the tiers above $500 million, and 29% for the small caps below that...